PharmTech AI Pulse Check episode 2 covers AI data governance, API-gated journals, watermarking limits, and why attribution beats detection in GxP.
|Articles|May 2, 2017
Jost Chemical Co.
Advertisement
For more than 30 years, Jost Chemical Co. has manufactured high purity chemical salts for the pharmaceutical, biopharmaceutical, and nutritional markets. Our FDA-registered site operates under bulk pharmaceutical cGMP. Jost’s products meet ICH Q3D elemental impurity guidelines and USP regulations per <232> and <233>, are BSE/TSE free, and Kosher and Halal certified.
8150 Lackland • St. Louis, Missouri 63114, USA
customer.service@jostchemical.com
tel. +1.314.428.4300
CPhI North America Booth #2559
Advertisement
Related to this article
The FDA opened an expedited IND pilot, tightened scrutiny of foreign trial data, and finalized a rule recognizing non-animal testing methods. In Europe, the EMA advanced pharmaceutical legislation reform, restricted 2 legacy products, and opened an injectable-iron safety review.
Novartis licenses Abogen's mRNA-encoded T-cell engager for autoimmune disease, raising scale-up questions for mRNA-lipid nanoparticle manufacturing.
Pharma manufacturing spent 90 years learning that producing correct outputs isn't the same as catching your own errors. AI has only learned the first.
Ron Scarboro, Azurity Pharmaceuticals, explains why real-world usability belongs at product definition and how post-launch feedback should guide drug formulation.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Gene manufacturing platforms, patient-centric formulations, contract services, packaging innovations, and sterile filling lines are in the spotlight at CPHI Milan 2026.
Ronald Piervincenzi, USP, explains why drug supply resilience needs a system approach, from procurement benchmarks to regulatory capacity building.
Advertisement
Advertisement